A French clip flags dry mouth and reflux in GLP-1 patients, plus a specific risk to watch for before sedation.
Recap by typeshit. Video by TikTok on TikTok.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
In the 308-person REMAIN-1 study, Revita patients held onto about 80% of their lost weight versus 67% with sham. Fractyl plans an FDA filing in late 2026.
A Nature paper examines real-world results when GLP-1 therapy is delivered to women mainly through a digital care model.
Loading…